Electric field cap with radiation for lung cancer brain metastases
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a wearable cap that uses gentle electrical fields (Tumor Treating Fields) along with focused radiation to treat brain metastases from non-small cell lung cancer. The goal is to see if this combination helps shrink or control the brain tumors better than radiation alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have newly diagnosed brain metastases from non-small cell lung cancer (NSCLC).
- You have 1 to 10 brain metastases, and they cannot be removed by surgery.
- You are able to care for yourself, at least with some help (KPS score of 70 or more).
- You can manage a wearable device that uses electrical fields, either by yourself or with help from a caregiver.
- You have not been found to have certain gene changes (like EGFR, ALK, or ROS1) that have targeted treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding a device that delivers electric fields (Tumor Treating Fields) to standard immunotherapy and chemotherapy for people with advanced non-small cell lung cancer that has not been treated before. It may help slow tumor growth.
This trial tests a wearable device that uses electric fields (called tumor treating fields) before surgery for early-stage non-small cell lung cancer. The goal is to see if it can help shrink the tumor and improve outcomes for patients.
This study tests a precise, targeted radiation technique for people with lung cancer that has spread to the brain. It aims to treat these brain tumors effectively while limiting harm to healthy tissue, which may help control the cancer and maintain quality of life.
This trial tests whether adding a precise, MRI-guided radiation treatment to tumor-treating electric fields (TTFields) can help people with recurrent glioblastoma. You may qualify if your tumor has come back 1 to 3 times after standard therapy and you haven't had certain prior treatments.
This trial tests a wearable device that sends electric fields (called Tumour Treating Fields) to the chest area, which may help slow or stop cancer growth. It is for people with non-small cell lung cancer that has a specific genetic change called EGFR mutation.
This trial tests whether combining brain radiation with chemotherapy and immunotherapy can help people with advanced lung cancer that has spread to the brain but has not yet been treated. It is for those whose tumors do not have certain gene mutations (EGFR, ALK, ROS1).
Hear when a new NSCLC Brain Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.